Related references
Note: Only part of the references are listed.Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies
Meng Zhao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Olivier Hermine et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia
Jonathan B. Parr
JAMA INTERNAL MEDICINE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
I. O. Rosas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
Chong-xiang Chen et al.
LEUKEMIA (2021)
Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
Timothy Arthur Chandos Snow et al.
INTENSIVE CARE MEDICINE (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
Ali Hassoun et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Sumanth Khadke et al.
VIROLOGY JOURNAL (2020)
Immune suppression in the early stage of COVID-19 disease
Wenmin Tian et al.
NATURE COMMUNICATIONS (2020)
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing-Yi Ge et al.
NATURE (2013)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)